517 related articles for article (PubMed ID: 9933436)
1. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory molecules in human periodontal disease tissues.
Gemmell E; McHugh GB; Grieco DA; Seymour GJ
J Periodontal Res; 2001 Apr; 36(2):92-100. PubMed ID: 11327084
[TBL] [Abstract][Full Text] [Related]
3. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.
Vyth-Dreese FA; Boot H; Dellemijn TA; Majoor DM; Oomen LC; Laman JD; Van Meurs M; De Weger RA; De Jong D
Immunology; 1998 Aug; 94(4):580-6. PubMed ID: 9767448
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of costimulatory molecules in myasthenia gravis.
Teleshova N; Matusevicius D; Kivisäkk P; Mustafa M; Pirskanen R; Link H
Muscle Nerve; 2000 Jun; 23(6):946-53. PubMed ID: 10842273
[TBL] [Abstract][Full Text] [Related]
5. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
6. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional role of co-stimulatory molecules in CD40+IL-4-stimulated B cells from atopic and non-atopic donors.
Oberwalleney G; Henz BM; Worm M
Acta Derm Venereol; 2000; 80(4):287-91. PubMed ID: 11028864
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory CD80/CD86-CD28/CD152 molecules in nasal mucosa of patients with perennial allergic rhinitis.
Hattori H; Okano M; Yoshino T; Akagi T; Nakayama E; Saito C; Satoskar AR; Ogawa T; Azuma M; Nishizaki K
Clin Exp Allergy; 2001 Aug; 31(8):1242-9. PubMed ID: 11529894
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
[TBL] [Abstract][Full Text] [Related]
10. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
11. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
[TBL] [Abstract][Full Text] [Related]
12. CD80 expression is induced on activated B cells following stimulation by CD86.
Sahoo NC; Rao KV; Natarajan K
Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition.
Costello RT; Mallet F; Sainty D; Maraninchi D; Gastaut JA; Olive D
Eur J Immunol; 1998 Jan; 28(1):90-103. PubMed ID: 9485189
[TBL] [Abstract][Full Text] [Related]
14. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
[TBL] [Abstract][Full Text] [Related]
15. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
16. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
17. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
18. Elevated CTLA-4 expression on CD4 T cells from periodontitis patients stimulated with Porphyromonas gingivalis outer membrane antigen.
Aoyagi T; Yamazaki K; Kabasawa-Katoh Y; Nakajima T; Yamashita N; Yoshie H; Hara K
Clin Exp Immunol; 2000 Feb; 119(2):280-6. PubMed ID: 10632663
[TBL] [Abstract][Full Text] [Related]
19. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
[TBL] [Abstract][Full Text] [Related]
20. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
Im SH; Barchan D; Souroujon MC; Fuchs S
J Immunol; 2000 Oct; 165(7):3599-605. PubMed ID: 11034361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
